New hope for elderly myeloma patients: easier treatment without transplant
NCT ID NCT03993912
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 22 times
Summary
This study tests whether adding daratumumab (given as a shot under the skin) to the standard drug lenalidomide helps frail older adults with newly diagnosed multiple myeloma live longer without their cancer getting worse. About 294 participants aged 65 and older who cannot have a stem cell transplant will receive either the new combo or standard treatment. The goal is to find a more effective and less toxic option for this vulnerable group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Saint-Malo
St-Malo, France
-
Centre Hospitalier de Perigueux
Périgueux, France
-
Centre Hospitalier de Saint Quentin
Saint-Quentin, France
-
Ch Blois Simone Veil
Blois, France
-
Ch Chartres Louis Pasteur-Le Coudray
Le Coudray, France
-
Ch Fleyriat
Bourg-en-Bresse, France
-
Chi Mont de Marsan Et Pays Des Sources
Mont-de-Marsan, France
-
Chru Brest Site Hopital Morvan
Brest, France
-
Chru Jean Minjoz
Besançon, France
-
Chru Rennes Site Pontchaillou
Rennes, France
-
Chu Dijon Bourgogne
Dijon, France
-
Chu Montpellier
Montpellier, France
-
Chu de Caen Normandie
Caen, France
-
Chu de Grenoble
Grenoble, France
-
Chu de Nantes Site Hotel Dieu Hme
Nantes, France
-
Chu de Nice Hopital de L'Archet
Nice, France
-
Chu de Tours
Tours, France
-
Gpe Hospitalier La Rochelle-Re-Aunis
La Rochelle, France
-
Hopital Haut-Leveque - Chu
Pessac, 33604, France
-
Hopital Prive Sevigne - Cesson
Cesson-Sévigné, France
-
Hôpital Claude Huriez, CHU
Lille, France
-
Institut Paoli Calmettes
Marseille, France
-
Oncopole Chu Toulouse
Toulouse, France
Conditions
Explore the condition pages connected to this study.